CALCIJEX Drug Patent Profile

✉ Email this page to a colleague

When do Calcijex patents expire, and when can generic versions of Calcijex launch?

Calcijex is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in CALCIJEX is calcitriol. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcitriol profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Calcijex

A generic version of CALCIJEX was approved as calcitriol by TEVA on October 12^th, 2001.

Try a Trial

Summary for CALCIJEX

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	90
Clinical Trials:	5
Patent Applications:	4,684
Formulation / Manufacturing:	see details
DailyMed Link:	CALCIJEX at DailyMed

Drug patent expirations by year for CALCIJEX

Recent Clinical Trials for CALCIJEX

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Cancer Institute (NCI)	Phase 1
Roswell Park Cancer Institute	Phase 1
Statistika Consultoria Ltda	Phase 4

See all CALCIJEX clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for CALCIJEX

A11CC	Vitamin D and analogues
A11C	VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO
A11	VITAMINS
A	Alimentary tract and metabolism

D05AX	Other antipsoriatics for topical use
D05A	ANTIPSORIATICS FOR TOPICAL USE
D05	ANTIPSORIATICS
D	Dermatologicals

US Patents and Regulatory Information for CALCIJEX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie	CALCIJEX	calcitriol	INJECTABLE;INJECTION	018874-001	Sep 25, 1986		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Abbvie	CALCIJEX	calcitriol	INJECTABLE;INJECTION	018874-002	Sep 25, 1986		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CALCIJEX

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	CALCIJEX	calcitriol	INJECTABLE;INJECTION	018874-002	Sep 25, 1986	⤷ Try a Trial	⤷ Try a Trial
Abbvie	CALCIJEX	calcitriol	INJECTABLE;INJECTION	018874-002	Sep 25, 1986	⤷ Try a Trial	⤷ Try a Trial
Abbvie	CALCIJEX	calcitriol	INJECTABLE;INJECTION	018874-001	Sep 25, 1986	⤷ Try a Trial	⤷ Try a Trial
Abbvie	CALCIJEX	calcitriol	INJECTABLE;INJECTION	018874-001	Sep 25, 1986	⤷ Try a Trial	⤷ Try a Trial
Abbvie	CALCIJEX	calcitriol	INJECTABLE;INJECTION	018874-001	Sep 25, 1986	⤷ Try a Trial	⤷ Try a Trial
Abbvie	CALCIJEX	calcitriol	INJECTABLE;INJECTION	018874-002	Sep 25, 1986	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CALCIJEX

See the table below for patents covering CALCIJEX around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Japan	S6144845		⤷ Try a Trial
Germany	3202622		⤷ Try a Trial
France	2126414		⤷ Try a Trial
Australia	7961382		⤷ Try a Trial
United Kingdom	1331011		⤷ Try a Trial
Switzerland	651208	COMPOSITION PHARMACEUTIQUE AQUEUSE DILUEE STABILISEE POUR L'ADMINISTRATION DU 1ALPHA,25-DIHYDROXYCHOLECALCIFEROL A DES NOUVEAUX-NES.	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for CALCIJEX

Recent Clinical Trials for CALCIJEX

Anatomical Therapeutic Chemical (ATC) Classes for CALCIJEX

Make Better Decisions: Try a trial or see plans & pricing